CRNX compared with XENE: revenue, margins and what each company keeps, and the suppliers and customers both name

CRNXCrinetics Pharmaceuticals, Inc.

Mkt capRevenueRevenue

XENEXenon Pharmaceuticals Inc.

Mkt capRevenueRevenue

Compare

CRNXCrinetics Pharmaceuticals, Inc.

XENEXenon Pharmaceuticals Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closesMethod ›

Moved together

CRNXwithXENE

Uncorrelated: r 0.24 · 460D.

Shared co-movers3with CRNXwith XENE

XNCRXencor Incr 0.33r 0.38

IDYAIDEAYA Biosciences, Inc.r 0.30r 0.42

DYNDyne Therapeutics, Inc.r 0.29r 0.40

CRNX, solidXENE, hatchedr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

CRNXCrinetics Pharmaceuticals, Inc.

84.97▲+0.15%

Mkt cap$509.7MRevenue$25MQ2 FY26Revenue$8MFY25

XENEXenon Pharmaceuticals Inc.

38.69▲+2.84%

Regular sessionNov 3 '26

Mkt cap$3.6BRevenue$8MQ1 FY25Revenue—

Compare

Regular sessionNov 3 '26

CRNXCrinetics Pharmaceuticals, Inc.

XENEXenon Pharmaceuticals Inc.

84.97▲+0.15%

Price

38.69▲+2.84%

$509.7M

Mkt cap

$3.6B

Q2 FY26$25M

Revenue

$8MQ1 FY25

FY25$8M

Revenue

—

CRNX84.97▲+0.15%vsXENE38.69▲+2.84%Regular sessionNov 3 '26